Redpoint Bio Corporation (OTC BB: RPBC), a leading biotechnology company, is focused on developing better tasting products for the pharmaceutical, food and beverage industries. The recent progression in taste biology has produced a number of new approaches to the discovery and development of innovative taste blockers and enhancers. The company leverages its modern tools of biotechnology to discover revolutionary ways to make medicines more palatable and enhance the taste of prepared foods and beverages. For further information, visit the Company’s web site at www.redpointbio.com.
- 18 years ago
QualityStocks
Redpoint Bio Corporation (OTC BB: RPBC)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline
VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded…
-
QualityStocksNewsBreaks – Hallmark Venture Group, Inc. (OTC: HLLK) Completes Drone Technology Acquisition, Transitions to Operating Business
Hallmark Venture Group (OTC: HLLK) announced the completion of a strategic transaction that transforms the company from…
-
QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced…